Stem cell treatment: A new hope for Multiple Sclerosis
RNL Bio Co., Ltd, (www.rnl.co.kr) a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that a 46-year-old female, Kang Sook Park’s Multiple Sclerosis improved tremendously after receiving stem cell treatment. Park was suffering from MS (Multiple Sclerosis), an autoimmune disease that affects the central nervous system (brain …
[Read the full article here]Related News:
Advancements in Stem Cell Research and Multiple Sclerosis Treatments
Fat Tissue Stem Cells Offer Hope For Multiple Sclerosis Treatment
Stem cells may cure multiple sclerosis–study